BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38058036)

  • 1. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation].
    Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
    [No Abstract]   [Full Text] [Related]  

  • 2. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
    Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
    Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular features of metanephric adenoma and their values in differential diagnosis].
    Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis.
    Pan CC; Tseng CE; Kuroda N; Yano M; Yasuda M; Nagashima Y; Yeh YC; Wang YC; Chang YH; Epstein JI
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):257-263. PubMed ID: 35384875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.
    Yin X; Zhang X; Pan X; Tan J; Zheng L; Zhou Q; Chen N
    Front Oncol; 2022; 12():1020456. PubMed ID: 36313688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.
    Catic A; Kurtovic-Kozaric A; Sophian A; Mazur L; Skenderi F; Hes O; Rohan S; Rakheja D; Kogan J; Pins MR
    BMC Med Genet; 2020 Oct; 21(1):202. PubMed ID: 33046021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma.
    Udager AM; Pan J; Magers MJ; Palapattu GS; Morgan TM; Montgomery JS; Weizer AZ; Hafez KS; Miller DC; Wolf JS; McHugh JB; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2015 Apr; 39(4):549-57. PubMed ID: 25602792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
    Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF mutations in metanephric adenoma of the kidney.
    Choueiri TK; Cheville J; Palescandolo E; Fay AP; Kantoff PW; Atkins MB; McKenney JK; Brown V; Lampron ME; Zhou M; Hirsch MS; Signoretti S
    Eur Urol; 2012 Nov; 62(5):917-22. PubMed ID: 22727996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
    Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
    Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric metanephric tumours: a clinicopathological and molecular characterisation.
    de Jel DVC; Hol JA; Ooms AHAG; de Krijger RR; Jongmans MCJ; Littooij AS; Drost J; van Grotel M; van den Heuvel-Eibrink MM
    Crit Rev Oncol Hematol; 2020 Jun; 150():102970. PubMed ID: 32371339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
    Muir TE; Cheville JC; Lager DJ
    Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition.
    Obasaju P; Shahab S; Dunn E; Rhee DS; Jiang L; Dome JS; Friedman AD; Argani P; Pratilas CA
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF mutations in pediatric metanephric tumors.
    Chami R; Yin M; Marrano P; Teerapakpinyo C; Shuangshoti S; Thorner PS
    Hum Pathol; 2015 Aug; 46(8):1153-61. PubMed ID: 26014474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
    Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
    Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.
    Day F; Muranyi A; Singh S; Shanmugam K; Williams D; Byrne D; Pham K; Palmieri M; Tie J; Grogan T; Gibbs P; Sieber O; Waring P; Desai J
    Target Oncol; 2015 Mar; 10(1):99-109. PubMed ID: 24859797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
    Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
    Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic-Based Immunohistochemistry Combined With Next-Generation Sequencing on Diagnostic Tissue Sections for Detection of Tumoral BRAF V600E Mutation.
    Leblond AL; Rechsteiner M; Jones A; Brajkovic S; Dupouy D; Soltermann A
    Am J Clin Pathol; 2019 Jun; 152(1):59-73. PubMed ID: 31065676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors.
    Marsden L; Jennings LJ; Gadd S; Yu M; Perlman EJ; Cajaiba MM
    Hum Pathol; 2017 Feb; 60():32-36. PubMed ID: 27769870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.